Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Shundong Dai"'
Autor:
Miaomiao Hao, Jie Zhang, Mingfang Sun, Kexin Diao, Jian Wang, Shiping Li, Qixue Cao, Shundong Dai, Xiaoyi Mi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tumor necrosis factor receptor associated factor 4 (TRAF4) is a RING domain E3 ubiquitin ligase that mediates the ubiquitination of various proteins and plays an important role in driving tumor progression. By studying the relationship between TRAF4
Externí odkaz:
https://doaj.org/article/81da87246c734b06bc67d1c7741fc279
Autor:
Xin Tian, Shundong Dai, Jing Sun, Shenyi Jiang, Chengguang Sui, Fandong Meng, Yan Li, Liye Fu, Tao Jiang, Yang Wang, Jia Su, Youhong Jiang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 39, Iss 5, Pp 2088-2098 (2016)
Background/Aims: Rapamycin is a potential anti-cancer agent, which modulates the activity of mTOR, a key regulator of cell growth and proliferation. However, several types of cancer cells are resistant to the anti-proliferative effects of rapamycin.
Externí odkaz:
https://doaj.org/article/4becf3cd992e400aa4f7669944c29322
Publikováno v:
Chinese Journal of Lung Cancer, Vol 13, Iss 9, Pp 856-860 (2010)
Background and objective DNA methyltransferase 1 (DNMT1) is one of the important molecules regulating DNA methylation. The abnormal expression of DNMT1 was associated with the methylation and inactivation of tumor suppressor gene and tumorigenesis. T
Externí odkaz:
https://doaj.org/article/2719693c324a4e87a9a8b1359f68816f
Autor:
Enhua WANG, Nan LIU, Zhiqiang YANG, Yang HAN, Qiang WEI, Yuan MIAO, Shundong DAI, Yue ZHAO, Yang LIU, Yan WANG, Lianhe YANG, Hongtao XU
Publikováno v:
Chinese Journal of Lung Cancer, Vol 11, Iss 2, Pp 214-219 (2008)
Background and objective TCF-4 is an important downstream molecule of Wnt signaling pathway, but studies on the expression level and significance of TCF-4 in lung cancer were still limited. The aim of this study is to examine the expression level of
Externí odkaz:
https://doaj.org/article/b8ae4bab925b4823b58f5ebd27526b36
Autor:
Guiyang Jiang, Chuifeng Fan, Xiupeng Zhang, Qianze Dong, Liang Wang, Yang Liu, Shundong Dai, Lianhe Yang, Yong Zhang, Juanhan Yu, Enhua Wang
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59183 (2013)
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation status is the most valuable indicator in the screening of non-small-cell lung cancer (NSCLC) patients for tyrosine kinase inhibitor (TKI) therapy. Accurate, rapid and economical methods of
Externí odkaz:
https://doaj.org/article/ade69396757d4ff79b2d78fdbc31f0fa
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e30303 (2012)
BackgroundThe different mechanisms involved in p120-catenin (p120ctn) isoforms' 1/3 regulation of cell cycle progression are still not elucidated to date.Methods and findingsWe found that both cyclin D1 and cyclin E could be effectively restored by r
Externí odkaz:
https://doaj.org/article/1a14b67098bd421ead5762b6c02d9c3a
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2020 (2020)
BioMed Research International, Vol 2020 (2020)
Purpose. Technetium-99m diethylene triamine pentaacetic acid (Tc-99m DTPA) renal dynamic scintigraphy is a widely used imaging technique that evaluates renal function of patients with extrarenal abnormalities, but its clinical value in potentially of
Short article: Sequence variations of PKHD1 underlie congenital hepatic fibrosis in a Chinese family
Publikováno v:
European Journal of Gastroenterology & Hepatology. 31:363-367
Congenital hepatic fibrosis (CHF) is a developmental disorder of the portobiliary system characterized by hepatic fibrosis, portal hypertension, and renal cystic disease. The aim of our study was to identify the disease-causing gene of a Chinese fami
Autor:
Dong Li, Shundong Dai, Xiongjun Wang, Xin Tian, Cuicui Kong, Guojiang Jin, Hua Yu, Pengchao Gong
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 29(3)
Epigenetic deregulation, especially mutagenesis or the abnormal expression of epigenetic regulatory factors (ERFs), plays an important role in malignant tumorigenesis. To screen natural inhibitors of breast cancer metastasis, we adopted small interfe
Autor:
Jia Su, Liye Fu, Shenyi Jiang, Jing Sun, Yan Li, Chengguang Sui, Xin Tian, Fandong Meng, Shundong Dai, Yang Wang, Tao Jiang, You-Hong Jiang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 39, Iss 5, Pp 2088-2098 (2016)
Background/Aims: Rapamycin is a potential anti-cancer agent, which modulates the activity of mTOR, a key regulator of cell growth and proliferation. However, several types of cancer cells are resistant to the anti-proliferative effects of rapamycin.